SK6592000A3 - Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances - Google Patents

Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances Download PDF

Info

Publication number
SK6592000A3
SK6592000A3 SK659-2000A SK6592000A SK6592000A3 SK 6592000 A3 SK6592000 A3 SK 6592000A3 SK 6592000 A SK6592000 A SK 6592000A SK 6592000 A3 SK6592000 A3 SK 6592000A3
Authority
SK
Slovakia
Prior art keywords
oily
delivery composition
pharmaceutical active
composition according
sticky
Prior art date
Application number
SK659-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Christer Karlsson
Per Johan Lundberg
Adam Rosinski
Malin Soderbom
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SK6592000A3 publication Critical patent/SK6592000A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK659-2000A 1997-11-28 1998-11-18 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances SK6592000A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704401A SE9704401D0 (sv) 1997-11-28 1997-11-28 Matrix pellets for greasy, oily or sticky drug substances
PCT/SE1998/002090 WO1999027913A1 (fr) 1997-11-28 1998-11-18 Pastilles matricielles de polyethylene glycol pour substances medicamenteuses grasses, huileuses ou gluantes

Publications (1)

Publication Number Publication Date
SK6592000A3 true SK6592000A3 (en) 2001-01-18

Family

ID=20409178

Family Applications (1)

Application Number Title Priority Date Filing Date
SK659-2000A SK6592000A3 (en) 1997-11-28 1998-11-18 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances

Country Status (23)

Country Link
US (2) US6555138B1 (fr)
EP (1) EP1032371B1 (fr)
JP (1) JP2001524514A (fr)
KR (1) KR20010032558A (fr)
CN (1) CN1280493A (fr)
AR (1) AR016684A1 (fr)
AT (1) ATE286382T1 (fr)
AU (1) AU746324B2 (fr)
BR (1) BR9814756A (fr)
CA (1) CA2311930A1 (fr)
DE (1) DE69828527T2 (fr)
HU (1) HUP0004405A3 (fr)
ID (1) ID24185A (fr)
IL (1) IL136144A0 (fr)
NO (1) NO20002720L (fr)
NZ (1) NZ504354A (fr)
PL (1) PL340926A1 (fr)
RU (1) RU2216316C2 (fr)
SE (1) SE9704401D0 (fr)
SK (1) SK6592000A3 (fr)
TW (1) TW570813B (fr)
WO (1) WO1999027913A1 (fr)
ZA (1) ZA9810465B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
SE9704401D0 (sv) * 1997-11-28 1997-11-28 Astra Ab Matrix pellets for greasy, oily or sticky drug substances
IT1319202B1 (it) 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
SE0201658D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
JP3887588B2 (ja) * 2002-08-30 2007-02-28 株式会社リガク Ｘ線回折による応力測定法
US8986737B2 (en) 2002-09-05 2015-03-24 Wm. Marsh Rice University Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth
PT1569912E (pt) 2002-12-03 2015-09-15 Pharmacyclics Llc Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia
US20070059358A1 (en) * 2003-07-02 2007-03-15 Tianjin Tasly Pharmaceutical Co., Ltd., China Matrix adjuvants and the drop pills prepared with them
EP2043613A1 (fr) * 2006-07-14 2009-04-08 Fmc Corporation Forme solide
WO2008074145A1 (fr) * 2006-12-20 2008-06-26 Genpharm Ulc Composition pharmaceutique comprenant un lubrifiant granulé thermofusible
AU2014201170B2 (en) * 2006-12-20 2015-09-24 Mylan Pharmaceuticals Ulc Pharmaceutical composition comprising a hot-melt granulated lubricant
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
JP6405369B2 (ja) 2013-09-19 2018-10-17 テルモ株式会社 ポリマー粒子
KR102505172B1 (ko) 2013-09-19 2023-02-28 마이크로벤션, 인코포레이티드 중합체 필름
BR112016010067B1 (pt) 2013-11-08 2023-01-10 Terumo Corporation Partículas de polímero e métodos de preparação
CN104133014B (zh) * 2014-07-16 2015-09-16 广州法尔麦兰药物技术有限公司 一种考察布洛伪麻缓释制剂释放度的方法
WO2016154592A1 (fr) 2015-03-26 2016-09-29 Microvention, Inc. Particules emboliques
US10201632B2 (en) 2016-09-28 2019-02-12 Terumo Corporation Polymer particles

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE557670C (de) 1932-08-26 Friedrich Rittershausen Abtast- bzw. Bildzusammensetzvorrichtung
DE454386C (de) 1924-05-27 1928-01-06 Chemische Produkte Vormals H S Verfahren zur Herstellung pharmazeutischer und diaetetischer Praeparate in kugelaehnlicher Form
US2699054A (en) 1953-10-09 1955-01-11 Lloyd H Conover Tetracycline
DE2251197C3 (de) 1972-10-19 1980-05-08 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von hxxochdosierten Tabletten von Tetracyclin- Derivaten
GB8613689D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
ATE76292T1 (de) * 1987-11-25 1992-06-15 American Cyanamid Co System fuer die verzoegerte (kontrollierte) freisetzung von substituierten dihydropyridincalciumantagonisten.
EP0621777B1 (fr) * 1992-01-17 1996-09-11 ALFATEC-PHARMA GmbH Corps solides renfermant une matiere active, a structure composee de macromolecules hydrophiles, et leur procede de fabrication
US5876754A (en) * 1992-01-17 1999-03-02 Alfatec-Pharma Gmbh Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
DE59209690D1 (de) * 1992-02-25 1999-06-10 Spirig Ag Minocyclin enthaltende Pellets
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
SE9704401D0 (sv) * 1997-11-28 1997-11-28 Astra Ab Matrix pellets for greasy, oily or sticky drug substances

Also Published As

Publication number Publication date
AU1356499A (en) 1999-06-16
JP2001524514A (ja) 2001-12-04
TW570813B (en) 2004-01-11
CA2311930A1 (fr) 1999-06-10
SE9704401D0 (sv) 1997-11-28
IL136144A0 (en) 2001-05-20
NO20002720D0 (no) 2000-05-26
RU2216316C2 (ru) 2003-11-20
AR016684A1 (es) 2001-07-25
BR9814756A (pt) 2000-10-03
DE69828527D1 (de) 2005-02-10
AU746324B2 (en) 2002-04-18
KR20010032558A (ko) 2001-04-25
US6555138B1 (en) 2003-04-29
CN1280493A (zh) 2001-01-17
DE69828527T2 (de) 2005-12-29
EP1032371B1 (fr) 2005-01-05
NZ504354A (en) 2001-12-21
ZA9810465B (en) 1999-05-21
ATE286382T1 (de) 2005-01-15
PL340926A1 (en) 2001-03-12
HUP0004405A3 (en) 2004-03-29
WO1999027913A1 (fr) 1999-06-10
ID24185A (id) 2000-07-13
HUP0004405A2 (hu) 2001-08-28
US20030175352A1 (en) 2003-09-18
NO20002720L (no) 2000-07-28
EP1032371A1 (fr) 2000-09-06

Similar Documents

Publication Publication Date Title
SK6592000A3 (en) Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
Sandor et al. Effect of protein molecular weight on release from micron-sized PLGA microspheres
US6077544A (en) Spheroids, preparation process and pharmaceutical compositions
EP2136792B1 (fr) Micropellets thermofusibles
JP2005516020A (ja) ゼロ次持続放出剤形およびその製造方法
CN105828806A (zh) 制剂
JP2010090146A (ja) 薬効を有する医薬の含有割合が高いメサラジンサッシェ
CN108159019A (zh) 非索非那定微胶囊及含有非索非那定微胶囊的组合物
EP1032391B1 (fr) Spheroides contenant tiagabine, procede de preparation et compositions pharmaceutiques
EP1032370B1 (fr) Particules poreuses d'hydroxyapatite comme excipients pour substances medicamenteuses
US20060115524A1 (en) Method for preparation of an agglomerate using melt agglomeration
JP2014516961A (ja) 多粒子医薬組成物
CZ20001945A3 (cs) Pelety z polyethylenglykolové matrice pro mastné, olejové nebo lepivé léčivé substance
Nguyen Extrusion-spheronization of pharmaceutical products: system for the delivery of active ingredients which are poorly soluble by oral route
MXPA00005112A (en) Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
MXPA00005116A (en) Porous hydroxyapatite particles as carriers for drug substances
CZ20001946A3 (cs) Porézní částice hydroxyapatitu jako nosiče léčivých substancí